01—Abstract
Summary
Summary of the 10-K filed December 20, 1996. Cited figures are marked; the original filing is the authoritative source.
Synopsys, Inc. (SNPS) closed fiscal 1996 (year ended September 30, 1996) with total revenue of $353.5 milliona, up 33% from $265.5 million in fiscal 1995, and continued strong top-line momentum in its core electronic design automation (EDA) business.
Service revenue grew 43% to $120.8 millionb, reaching 34% of total revenue, which supports a growing recurring base of maintenance, support, and consulting income. Gross margin held at roughly 89%, and operating cash flow was a healthy $88.3 million, though reported net income fell 22% to $23.7 million (EPS $0.57) from $30.3 million, largely because of a one-time $39.7 million in-process R&D charge tied to the February 1996 IBM joint development agreement. Excluding that charge, operating income would have been roughly $68.6 million, versus $42.8 million in fiscal 1995, so underlying profitability improved meaningfully.
Investors should weigh the company's heavy investment posture: R&D rose 44% to $84.2 millionc (24% of revenue), sales and marketing reached $134.1 million, and management expects R&D to stay near the fiscal 1996 percentage of revenue in fiscal 1997. The balance sheet is strong, with $236.6 million in cash and short-term investments against $16.0 million of long-term debt, largely the notes issued to IBM. Backlog rose to $176.4 million from $99.4 million a year earlier, a positive signal, though management cautions that revenue recognition is becoming less predictable as orders shift toward multi-quarter and time-based licenses.
Risk factors highlighted in the filing include intense competition from Cadence, Mentor Graphics, Viewlogic, and Avant!, a pending Cadence-CCT merger affecting Synopsys' strategic stake in Cooper & Chyan, exposure to yen weakness (international revenue is about half of sales), slowing semiconductor industry growth, and the company's reliance on a synthesis franchise where market share gains are limited. The filing reports no material legal proceedings.
02—Key points
Key Highlights
- Total revenue rose 33% to $353.5 million in fiscal 1996, with product revenue up 29% to $232.7 million and service revenue up 43% to $120.8 million
- Net income declined 22% to $23.7 million ($0.57 per share), primarily due to a $39.7 million one-time in-process R&D charge from the IBM joint development agreement
- Operating cash flow of $88.3 million and $236.6 million in cash and short-term investments provide substantial financial flexibility
- Backlog increased to $176.4 million as of November 2, 1996, up from $99.4 million a year earlier
- R&D spending increased 44% to $84.2 million, reflecting continued heavy investment in new products such as Cyclone, ARKOS emulator, and Power Compiler
- Strategic partnerships with IBM (six-year joint development deal) and SEMATECH ($6 million contract) strengthen the technology roadmap, though the CCT relationship is under review due to the Cadence merger
- International revenue accounted for 49% of total sales, with yen weakness weighing on Japan revenue during fiscal 1996
03—Questions
Frequently Asked Questions
Why did Synopsys' net income fall in fiscal 1996 even though revenue grew 33%?
The main driver was a $39.7 million in-process research and development charge recorded in the second quarter of fiscal 1996 in connection with the February 1996 IBM joint development and license agreement. Excluding this one-time charge, operating income would have risen substantially from $42.8 million in fiscal 1995 to roughly $68.6 million, although rising R&D and sales and marketing spending also increased operating costs.
How strong is Synopsys' balance sheet and cash position?
The company ended fiscal 1996 with $236.6 million in cash and short-term investments, up $26.6 million for the year, and total stockholders' equity of $232.7 million. Long-term debt was $16.0 million, consisting primarily of notes payable to IBM. Operating cash flow of $88.3 million comfortably funded $39.2 million in capital expenditures, the CCT investment, and $14.8 million in share repurchases.
What does the growing backlog and service revenue mean for future earnings quality?
Backlog increased to $176.4 million from $99.4 million, and service revenue, which includes maintenance, support, training, and consulting, grew to 34% of total revenue from 31% in fiscal 1994. This recurring revenue base improves visibility. However, management warns that more orders now involve multi-quarter or time-based licenses, making quarterly revenue recognition less predictable than in the past.
What are the main risks to Synopsys' competitive position?
The company faces intense competition from Cadence, Mentor Graphics, Viewlogic, Avant!, and Quickturn. Its synthesis franchise is the market leader, but management acknowledges limited growth opportunities in that segment. Synopsys does not offer physical design tools, a market dominated by Cadence and Avant!, and the pending Cadence-CCT merger creates uncertainty around its strategic relationship with Cooper & Chyan. Continued yen weakness and slower semiconductor industry growth also pose risks.
Are there any material legal proceedings or ownership concerns for investors to note?
The filing states there are no material legal proceedings pending against the company. The stock trades on the NASDAQ National Market under the symbol SNPS, with approximately 277 holders of record as of October 31, 1996. The company has never paid cash dividends and does not anticipate doing so in the foreseeable future, and it repurchased 361,494 shares during fiscal 1996 under a 2.0 million share authorization.
04—Continue